Atlas Trials

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Clinical trial NCT01185028 · COMPLETED

Trial details

NCT number
NCT01185028
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatitis C InfectionHIV Infection
Start date
2010-08-01
Primary completion
2011-10-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.